Valuation: Hologic, Inc.

Market Cap 16.97B 15.16B 14.15B 12.85B 24.2B 1,641B 24.38B 170B 66.41B 835B 63.7B 62.33B 2,684B P/E 2024
24.3x
P/E 2025 27x
Enterprise Value 17.39B 15.54B 14.5B 13.17B 24.8B 1,682B 24.98B 174B 68.06B 856B 65.28B 63.87B 2,750B EV / Sales 2024
4.74x
EV / Sales 2025 3.75x
Free-Float
73.08%
Yield 2024 *
-
Yield 2025 -
1 day+0.48%
Current year+2.04%
Current year 74.49
Extreme 74.49
76.07
1 year 65
Extreme 65
76.07
3 years 51.9
Extreme 51.9
84.67
5 years 51.9
Extreme 51.9
87.88
10 years 26.49
Extreme 26.49
87.88
Manager TitleAgeSince
Chief Executive Officer 63 07/04/2026
Director of Finance/CFO - 16/04/2026
Chief Operating Officer 46 01/01/2024
Director TitleAgeSince
Director/Board Member 63 07/04/2026
Date Insider Type Main position Quantity % Market Cap. Importance
7/4/26 Issuer sale

Director

19,583 0.0088%
7/4/26 Issuer sale

General Counsel

72,500 0.0325%
7/4/26 Issuer sale

Executive/Senior Manager

123,246 0.0552%
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%-.--%+12.23%+8.83% 16.97B
+0.83%-1.92%+22.79%+32.80% 245B
+1.34%-1.38%+4.66%+0.58% 154B
+2.41%+1.94%-5.99%+40.19% 146B
-1.45%-4.74%-56.64%-20.22% 60.26B
-0.81%-0.63%+11.81%+16.39% 49.44B
-0.14%-1.87%+22.03%+52.83% 47.67B
-0.58%+1.75%-21.16%-18.54% 48.04B
-0.35%-1.03%-7.75%+34.78% 45.74B
-0.10%-0.77%+36.95%+63.05% 42.84B
Average -0.13%-1.49%+1.89%+21.07% 85.58B
Weighted average by Cap. -0.19%-2.05%+4.74%+22.98%

Financials

2024 2025
Net sales 4.03B 3.6B 3.36B 3.05B 5.75B 390B 5.79B 40.37B 15.77B 198B 15.13B 14.8B 637B 4.1B 3.66B 3.42B 3.1B 5.85B 397B 5.89B 41.08B 16.05B 202B 15.39B 15.06B 649B
Net income 790M 705M 658M 598M 1.13B 76.37B 1.13B 7.91B 3.09B 38.84B 2.96B 2.9B 125B 566M 505M 472M 428M 807M 54.72B 813M 5.67B 2.21B 27.83B 2.12B 2.08B 89.47B
Net Debt 321M 287M 268M 243M 458M 31.08B 462M 3.22B 1.26B 15.81B 1.21B 1.18B 50.81B 421M 376M 351M 319M 600M 40.72B 605M 4.22B 1.65B 20.71B 1.58B 1.55B 66.57B
Projected Income Statement - Annual - Hologic, Inc.
Logo Hologic, Inc.
Hologic, Inc. is a medical technology company primarily focused on improving women's health and well-being through early detection and treatment. The Company is a developer, manufacturer and supplier of diagnostics products, medical imaging systems, and surgical products. Its segments include Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The Diagnostics segment offers a range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. The Breast Health segment offers a broad portfolio of solutions for breast imaging, biopsy, breast surgery and pathology. The GYN Surgical segment's products include MyoSure hysteroscopic tissue removal system, NovaSure endometrial ablation system, Acessa ProVu laparoscopic radiofrequency ablation system, as well as CoolSeal vessel sealing portfolio and JustRight surgical stapler. The Skeletal Health segment's products include the Horizon DXA and the Fluoroscan Insight FD mini C-arm.
Employees
7,070
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Ratings Surperformance© - Hologic, Inc.
  1. Stock Market
  2. Stocks
  3. HOLX Stock